Clinical trial design is complex and especially more so for a small biotech company that needs to be balance finances. Proof of concept trials are often done with smaller groups of patients to expedite the process at a more affordable cost. We are not privy to all the details involved in the decision analysis. Hindsight is often 20/20. I have been patiently following this company as a shareholder from inception and have thus far been overall satisfied with management and trial progression. I have both a medical and scientific background and have actively been following small biotech companies for the past 20+ years. I have a strong understanding of the complexities of the process. I strongly believe the next 2 years will be very rewarding for those that patiently wait for future progress!
News 
Market Data 
Discover 
